Virtu Financial LLC Alterity Therapeutics LTD Transaction History

Virtu Financial LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$0.01 - $0.02 $195 - $391	-19,590 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$0.01 - $0.02 $195 - $391	19,590 New	19,590 $16,000
Q4 2021 Feb 17, 2022	SELL	$0.01 - $0.02 $113 - $227	-11,351 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$0.02 - $0.03 $227 - $340	11,351 New	11,351 $14,000
Q2 2021 Sep 17, 2021	SELL	$0.02 - $0.03 $1,398 - $2,097	-69,905 Closed	0 $0
Q1 2021 May 19, 2021	BUY	$0.02 - $0.03 $1,398 - $2,097	69,905 New	69,905 $101,000

Ticker ATHE
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,114,600
Market Cap $42.9M
Description
Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434 that has completed Phase I clinical trial for the treatment of Parkinson's disease. It is also...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.